Cita APA

Fernández-Plana, J., Pericay, C., Quintero, G., Alonso, V., Salud Salvia, M. A., Méndez, M., . . . Cirera, L. (2014). Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study).

Citación estilo Chicago

Fernández-Plana, Julen, Carles Pericay, Guillermo Quintero, Vicente Alonso, Maria Antonieta Salud Salvia, Miguel Méndez, Mercedes Salgado, Eugeni Saigi, y Luis Cirera. Biweekly Cetuximab in Combination With FOLFOX-4 in the First-line Treatment of Wild-type KRAS Metastatic Colorectal Cancer: Final Results of a Phase II, Open-label, Clinical Trial (OPTIMIX-ACROSS Study). 2014.

Cita MLA

Fernández-Plana, Julen, et al. Biweekly Cetuximab in Combination With FOLFOX-4 in the First-line Treatment of Wild-type KRAS Metastatic Colorectal Cancer: Final Results of a Phase II, Open-label, Clinical Trial (OPTIMIX-ACROSS Study). 2014.